Investigate the application of postoperative ctDNA-based molecular residual disease detection in monitoring tumor recurrence in patients with non-small cell lung cancer——A retrospective study of ctDNA

Investigate the application of postoperative ctDNA-based molecular residual disease detection in monitoring tumor recurrence in patients with non-small cell lung cancer——A retrospective study of ctDNA

PurposeTo evaluate whether postoperative circulating tumor DNA (ctDNA) in plasma of patients with non-small cell lung cancer (NSCLC) can be used as a biomarker for early detection of molecular residual disease (MRD) and prediction of postoperative recurrence.MethodsThis study subjects were evaluated...

Full description

Bibliographic Details
Main Authors: Xuefei Zhang, Youguo Zhang, Shanli Zhang, Sha Wang, Peng Yang, Changhong Liu
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-04-01
Series:Frontiers in Oncology
Subjects:
NSCLC1
ctDNA2
molecular residual disease (MRD)3
postoperative 4
recurrence risk 5
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2023.1098128/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2023.1098128/full

Similar Items